Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Recommendation of "Moderate Buy" by Analysts

Key Points

• Analysts have rated Nkarta, Inc. (NASDAQ:NKTX) with a consensus "Moderate Buy," with recommendations that include four buy ratings, one hold, and one sell.
• The company's stock price target among analysts is set at an average of $13.50, although recent ratings from analysts have seen target prices adjusted lower by some firms.
• Despite the positive sentiment, Nkarta's stock has recently dropped 8.5% and currently trades at $2.16, significantly below its 52-week high of $4.55.

Shares of Nkarta, Inc. (NASDAQ:NKTX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the six analysts that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $13.50.

Several equities research analysts recently commented on the company. Weiss Ratings reissued a "sell (e+)" rating on shares of Nkarta in a report on Wednesday, October 8th. Stifel Nicolaus cut their target price on Nkarta from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Thursday, August 14th. Wall Street Zen downgraded Nkarta from a "hold" rating to a "sell" rating in a research report on Friday, October 3rd. Finally, Needham & Company LLC restated a "buy" rating and issued a $10.00 target price on shares of Nkarta in a research report on Wednesday, August 13th.

Institutional Trading of Nkarta

Several institutional investors and hedge funds have recently added to or reduced their stakes in NKTX. Wealth Enhancement Advisory Services LLC acquired a new stake in Nkarta during the first quarter valued at approximately $32,000. Savant Capital LLC acquired a new stake in Nkarta during the second quarter valued at approximately $36,000. CWM LLC lifted its stake in Nkarta by 3,437.3% during the first quarter. CWM LLC now owns 28,157 shares of the company's stock valued at $52,000 after purchasing an additional 27,361 shares during the last quarter. Cerity Partners LLC acquired a new stake in Nkarta during the first quarter valued at approximately $55,000. Finally, Deutsche Bank AG lifted its stake in Nkarta by 36.3% during the first quarter. Deutsche Bank AG now owns 58,812 shares of the company's stock valued at $108,000 after purchasing an additional 15,655 shares during the last quarter. 80.54% of the stock is owned by institutional investors and hedge funds.

Nkarta Stock Down 8.5%

Nkarta stock opened at $2.16 on Monday. The firm has a 50-day moving average price of $2.12 and a two-hundred day moving average price of $1.95. The firm has a market capitalization of $153.42 million, a price-to-earnings ratio of -1.46 and a beta of 0.86. Nkarta has a 52-week low of $1.31 and a 52-week high of $4.55.

Nkarta (NASDAQ:NKTX - Get Free Report) last posted its earnings results on Tuesday, August 12th. The company reported ($0.31) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.37) by $0.06. Research analysts expect that Nkarta will post -1.7 earnings per share for the current year.

About Nkarta

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen that is in Phase 1 clinical trial for the treatment of relapsed/refractory (r/r) non-hodgkin lymphoma, as well as for lupus nephritis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.